Lobe Sciences Ltd. (LOBEF)
OTCMKTS · Delayed Price · Currency is USD
0.0362
0.00 (0.00%)
Feb 12, 2026, 3:35 PM EST
Lobe Sciences Market Cap
Lobe Sciences has a market cap or net worth of $9.95 million as of February 12, 2026. Its market cap has increased by 294.36% in one year.
Market Cap
9.95M
Enterprise Value
6.61M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.04
Market Cap Chart
Since June 7, 2019, Lobe Sciences's market cap has decreased from 13.11M to 9.95M, a decrease of -24.06%. That is a compound annual growth rate of -4.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 9.95M | 12.32% |
| Dec 30, 2025 | 8.86M | 178.34% |
| Dec 31, 2024 | 3.18M | 112.53% |
| Dec 29, 2023 | 1.50M | -33.91% |
| Dec 30, 2022 | 2.27M | -57.44% |
| Dec 31, 2021 | 5.33M | -73.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HOOKIPA Pharma | 13.63M |
| TRON Group | 11.43M |
| AccuStem Sciences | 10.19M |
| Inhibitor Therapeutics | 9.79M |
| Biomind Labs | 8.84M |
| NKGen Biotech | 7.84M |
| Curative Biotechnology | 7.75M |
| BetterLife Pharma | 7.44M |